Skip to content
10-Q

Quarterly Report

Galileo Life Sciences, Inc.

0001199835-16-000635

← back to feed
Filed
Feb 22, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Jan 27, 2016 127.55M sh
Operating Cash Flow Q2 2015 · Dec 31, 2014 −$107.53K
Operating Cash Flow Q2 2015 · Dec 31, 2013 −$8.7K
Stockholders Equity Q2 2015 · Dec 31, 2014 −$540.23K
Stockholders Equity Q2 2015 · Jun 30, 2014 −$667.05K
Current Liabilities Q2 2015 · Dec 31, 2014 $609.08K
Current Liabilities Q2 2015 · Jun 30, 2014 $725.47K
Total Liabilities Q2 2015 · Dec 31, 2014 $609.08K
Total Liabilities Q2 2015 · Jun 30, 2014 $725.47K
Current Assets Q2 2015 · Dec 31, 2014 $2.56K
Current Assets Q2 2015 · Jun 30, 2014 $12.41K
Total Assets Q2 2015 · Dec 31, 2014 $68.85K
Total Assets Q2 2015 · Jun 30, 2014 $58.42K
Sga Expense Q2 2015 · Dec 31, 2014 $2.44K
Sga Expense Q2 2015 · Dec 31, 2014 $4.88K
Sga Expense Q2 2015 · Dec 31, 2013 $19
Sga Expense Q2 2015 · Dec 31, 2013 $357
Net Income Q2 2015 · Dec 31, 2014 −$932.38K
Net Income Q2 2015 · Dec 31, 2014 −$1.22M
Net Income Q2 2015 · Dec 31, 2013 −$29.09K
Net Income Q2 2015 · Dec 31, 2013 −$39.86K
Operating Income Q2 2015 · Dec 31, 2014 −$934.85K
Operating Income Q2 2015 · Dec 31, 2014 −$1.23M
Operating Income Q2 2015 · Dec 31, 2013 −$31.53K
Operating Income restated Q2 2015 · Dec 31, 2013 −$40.51K
Revenue Q2 2015 · Dec 31, 2014 $0
Revenue Q2 2015 · Dec 31, 2014 $0
Revenue Q2 2015 · Dec 31, 2013 $0
Revenue Q2 2015 · Dec 31, 2013 $0